Trials / Sponsors / Shenzhen Institute for Innovation and Translational Medicine
Shenzhen Institute for Innovation and Translational Medicine
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Lymphoma | Phase 1 / Phase 2 | 2016-01-15 |